Volume 104, Issue 3, Pages (February 2001)

Slides:



Advertisements
Similar presentations
Volume 6, Issue 1, Pages (July 2000)
Advertisements

Selective Regulation of Vitamin D Receptor-Responsive Genes by TFIIH
Large Hepatitis Delta Antigen Modulates Transforming Growth Factor-β Signaling Cascades: Implication of Hepatitis Delta Virus–Induced Liver Fibrosis 
BRCA1 Is Associated with a Human SWI/SNF-Related Complex
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Volume 19, Issue 4, Pages (August 2005)
Purusharth Rajyaguru, Meipei She, Roy Parker  Molecular Cell 
by Katriina J. Peltola, Kirsi Paukku, Teija L. T
Volume 5, Issue 5, Pages (May 2004)
Volume 5, Issue 2, Pages (February 2000)
Nicolas Charlet-B, Gopal Singh, Thomas A. Cooper  Molecular Cell 
Volume 94, Issue 1, Pages (July 1998)
Volume 3, Issue 1, Pages (January 1999)
Volume 16, Issue 6, Pages (December 2004)
Volume 23, Issue 1, Pages (July 2006)
A Mechanism for Inhibiting the SUMO Pathway
Arginine Methylation of STAT1 Modulates IFNα/β-Induced Transcription
A Human Nuclear-Localized Chaperone that Regulates Dimerization, DNA Binding, and Transcriptional Activity of bZIP Proteins  Ching-Man A Virbasius, Susanne.
Yongli Bai, Chun Yang, Kathrin Hu, Chris Elly, Yun-Cai Liu 
HDAC Activity Is Required for p65/RelA-Dependent Repression of PPARδ-Mediated Transactivation in Human Keratinocytes  Lene Aarenstrup, Esben Noerregaard.
John F Ross, Xuan Liu, Brian David Dynlacht  Molecular Cell 
Ras Induces Mediator Complex Exchange on C/EBPβ
Robert L.S Perry, Maura H Parker, Michael A Rudnicki  Molecular Cell 
SUMO Promotes HDAC-Mediated Transcriptional Repression
Volume 29, Issue 4, Pages (February 2008)
Volume 93, Issue 5, Pages (May 1998)
Transcription Factor MIZ-1 Is Regulated via Microtubule Association
Vanessa Brès, Tomonori Yoshida, Loni Pickle, Katherine A. Jones 
Volume 96, Issue 3, Pages (February 1999)
Naoko Kanda, Shinichi Watanabe  Journal of Investigative Dermatology 
Volume 118, Issue 1, Pages (July 2004)
The p400 Complex Is an Essential E1A Transformation Target
Volume 10, Issue 5, Pages (November 2002)
Volume 7, Issue 4, Pages (April 2001)
Volume 6, Issue 1, Pages (July 2000)
Shijiao Huang, Danming Tang, Yanzhuang Wang  Developmental Cell 
The TBN Protein, which Is Essential for Early Embryonic Mouse Development, Is an Inducible TAFII Implicated In Adipogenesis  Mohamed Guermah, Kai Ge,
Per Stehmeier, Stefan Muller  Molecular Cell 
MyoD Targets TAF3/TRF3 to Activate Myogenin Transcription
c-Src Activates Endonuclease-Mediated mRNA Decay
Phosphorylation on Thr-55 by TAF1 Mediates Degradation of p53
Volume 1, Issue 2, Pages (January 1998)
Volume 90, Issue 4, Pages (August 1997)
Volume 96, Issue 3, Pages (February 1999)
Volume 115, Issue 2, Pages (October 2003)
Andrei Kuzmichev, Thomas Jenuwein, Paul Tempst, Danny Reinberg 
Volume 19, Issue 6, Pages (September 2005)
Volume 31, Issue 6, Pages (September 2008)
Heterochromatin Dynamics in Mouse Cells
Dimitra J. Mitsiou, Hendrik G. Stunnenberg  Molecular Cell 
Cyclin G Recruits PP2A to Dephosphorylate Mdm2
Volume 17, Issue 8, Pages (April 2007)
S Phase Activation of the Histone H2B Promoter by OCA-S, a Coactivator Complex that Contains GAPDH as a Key Component  Lei Zheng, Robert G Roeder, Yan.
Two Functional Modes of a Nuclear Receptor-Recruited Arginine Methyltransferase in Transcriptional Activation  María J. Barrero, Sohail Malik  Molecular.
Volume 125, Issue 4, Pages (May 2006)
Shrestha Ghosh, Baohua Liu, Yi Wang, Quan Hao, Zhongjun Zhou 
Naoko Kanda, Shinichi Watanabe  Journal of Investigative Dermatology 
Antonio Porro, Sascha Feuerhahn, Joachim Lingner  Cell Reports 
In Vitro Analysis of Huntingtin-Mediated Transcriptional Repression Reveals Multiple Transcription Factor Targets  Weiguo Zhai, Hyunkyung Jeong, Libin.
Volume 14, Issue 2, Pages (April 2004)
Volume 13, Issue 3, Pages (February 2004)
Reconstitution of the Transcription Factor TFIIH
Volume 9, Issue 1, Pages (January 2002)
Volume 4, Issue 4, Pages (October 1999)
Volume 7, Issue 6, Pages (June 2001)
Volume 13, Issue 14, Pages (July 2003)
Volume 104, Issue 1, Pages (January 2001)
Volume 3, Issue 1, Pages (January 1999)
Gα12 and Gα13 Interact with Ser/Thr Protein Phosphatase Type 5 and Stimulate Its Phosphatase Activity  Yoshiaki Yamaguchi, Hironori Katoh, Kazutoshi Mori,
Acetylation Regulates Transcription Factor Activity at Multiple Levels
Presentation transcript:

Volume 104, Issue 3, Pages 353-363 (February 2001) Defective Interplay of Activators and Repressors with TFIIH in Xeroderma Pigmentosum  Juhong Liu, Sasha Akoulitchev, Achim Weber, Hui Ge, Sergei Chuikov, Daniel Libutti, Xin W Wang, Joan Weliky Conaway, Curtis C Harris, Ronald C Conaway, Danny Reinberg, David Levens  Cell  Volume 104, Issue 3, Pages 353-363 (February 2001) DOI: 10.1016/S0092-8674(01)00223-9

Figure 1 The Activation Domain of FBP Makes Multiple TFIIH Contacts (A) Purified recombinant FPBC bound to Ni+-chelated beads mixed with 5 μg of HeLa nuclear extract. Purified proteins were analyzed using antibodies against components of the basal machinery. TFIIH subunits p62, p89, and Cyclin H consistently copurified with FBPC. (B) FBP interacts with TFIIH in vivo. His-tagged FBP was transfected into HeLa cells, purified by Ni-NTA resin, and blotted with α-p62. (C) FBPC directly interacts with p62. Left panel: GSTp62 or GST was bound to glutathione beads and mixed with recombinant FBPC. FBPC was detected by α-T7 antibody. FBPC and its degradation products copurified with GSTp62 (lane 1) but not GST (lane 2). Right panel: 2 μg of indicated proteins were separated on SDS-PAGE gel, renatured, and probed with 125I- FBPC. p62 and its degradation fragments specifically interacted with FBPC. As a positive control, FAR protein (35 kDa) was also recognized by FBPC. (D) FBPC makes multiple contacts with TFIIH. In vitro translated 35S-HA-FBPC was bound to HA-affinity matrix and incubated with equal counts of in vitro translated 35S-FAR, Luciferase, p62, p89, or p80 in the presence of 50 ng/μl of BSA (lanes 1, 3, 5, 7, 9) or hisFBPC (lanes 2,4, 6, 8, 10). p62, p89, and p80 as well as FAR copurified with HA-FBPC. Preblocking with soluble recombinant FBPC abolished the interaction Cell 2001 104, 353-363DOI: (10.1016/S0092-8674(01)00223-9)

Figure 2 FBPC Activated p89 Helicase Activity and Stimulated Transcription Initiation (A) FBPC stimulated holo-TFIIH and p89-helicase activities. 10 ng of purified human TFIIH (lanes 5–7), 40 ng of insect cell expressed p89 (lanes 8–10), or 1 ng of SV40 T-antigen (lanes 11–13) was mixed with 100 ng or 400 ng of HPLC-purified recombinant FBPC. BSA was used to adjust the total protein. FBPC stimulated the helicase activity of holo-TFIIH and p89, but not T-antigen. FBPC alone was inactive. The relative helicase as determined by densitometry is indicated. (B) FBPC stimulated initiation. 25 ng of recombinant G494 or G4FBPC was added to a transcription system reconstituted from highly purified components and A,CTP (lanes 1 and 2) or A,C,UTP (lanes 3 and 4). G4FBPC stimulated both dinucleotide synthesis (lane 2 versus 1) and productive transcription (lane 4 versus 3) Cell 2001 104, 353-363DOI: (10.1016/S0092-8674(01)00223-9)

Figure 3 FBPC Stimulated Both Initiation and Promoter Escape, but FIR Expressed Only Promoter Escape (A) Assays used a system reconstituted from purified factors and 10, 25, or 150 ng of recombinant FIR and A,CTP (lanes 1–5) or A,C,UTP (lanes 6–10). G4FBPC (25 ng) increased dinucleotide synthesis (lane 2) and full-length transcript (lanes 7, upper band). FIR repressed run-off transcription (lanes 8–10, upper band), but failed to repress initiation (lanes 3–5). Basal transcription of AdMLP was not affected by FIR (lanes 6 through 10, lower band). (B) Both FBPC and FIR operate after preinitiation complex formation. Left: Reconstituted transcription reactions used immobilized template. Lanes were loaded to normalize for the full-length transcripts (FL). Besides stimulating initiation (dinucleotide synthesis), G4FBPC stimulated promoter escape by eliminating pausing at positions 2, 3, 7, and 11 (lane 3). G4VP16 also augmented the transition to promoter escape (lane 2). Addition of 150 ng of FIR reversed the FBPC effect on pausing (lane 5) but still allowed initiation. FIR caused partial pausing at 35 nucleotides. Right panel: 75 ng of affinity-purified polyclonal α-FBPC was added either before PIC formation (lane 3) or after dinucleotide synthesis (lane 4). α-FBPC inhibited activated transcription in both cases. The input ratio of activated/basal template was reduced in this experiment Cell 2001 104, 353-363DOI: (10.1016/S0092-8674(01)00223-9)

Figure 4 FBPC Activation Is Impaired by XPB and XPD Mutations unless Complemented with wtTFIIH (A) Immortalized lymphoblast XPB cells were transfected with plasmids expressing G4FBPC, G4VP16, or G4E1a fusion proteins and a CAT reporter under GAL4UAS control. Empty vector or wild-type XPB expression vector was also transfected. FBPC did not activate in XPB cells (lane 1), but VP16 and E1a did (lanes 3 and 5). FBPC activation was rescued by cotransfecting wild-type XPB (lane 2). The CAT activities of the various activators +/−XPB are graphed. (B) XPD-deficient cells are impaired, but not incapacitated for FBPC activation. XPD fibroblasts were transfected as described in (A). The XPD mutation decreased (lane 1), and wtXPD rescued (lane 2) FBPC activity. VP16 and E1a were not affected by the XPD mutation (lanes 3 to 6). CAT is graphed (right). (C) In vitro transcription using HeLa, XPB, and XPD nuclear extracts yielded parallel results. G4FBPC activated transcription better than G4VP16 in HeLa nuclear extract (lane 2 and 3), but FBPC activation was severely impaired compared to VP16 in XPB or XPD nuclear extracts (lanes 5 versus 6 and 11 versus 12). The relative activity of G4FBPC and G4VP16, and the relative stimulation upon addition of TFIIH, were determined by denistometry. Purified rat TFIIH rescued FBPC activation (lane 8 versus 9, 14 versus 15). (D) FBPC does not bind mutated TFIIH. As in Figure 1A, purified hisFBPC was bound to Ni2+ beads and mixed with HeLa (5 μg), XPB (25 μg), or XPD (5 μg) nuclear extract. Eluates were probed with α-p62 or α-T7. Input (10%) was also loaded (Lanes 1–3). FBPC copurified with wtTFIIH in HeLa (lane 4) but not mutated TFIIH from XPB or XPD nuclear extracts (lane 5 and 6, respectively) Cell 2001 104, 353-363DOI: (10.1016/S0092-8674(01)00223-9)

Figure 5 FBP Regulation of Endogenous c-myc Is Impaired in XPB Fibroblasts XPB cells were transfected with dominant negative GFP-FBPcd in the presence or absence of wt p89 and stained for Myc. In mutant cells, GFP-FBPcd failed to repress c-myc (lower left panel). Endogenous Myc was reduced sharply by FBPcd and wtXPB/p89 cotransfection Cell 2001 104, 353-363DOI: (10.1016/S0092-8674(01)00223-9)

Figure 6 Repression by FIR Required Wild-Type TFIIH (A) XPB, XPD, and HeLa cells were transfected with pG4E1a and a FIR expression vector. Transiently expressed FIR repressed G4E1a HeLa (lanes 7–9). FIR repression required higher doses in XPD cells (lanes 4–6), whereas FIR was completely incapable of repression in XPB cells (lanes 1–3). (B) FIR failed to form a stable complex with defective TFIIH. Upper panel: immunoprecipitation with monoclonal α-p89. Normal mouse IgG was used as the control antibody. FIR copurified with TFIIH in HeLa but not XPB nuclear extract. Input protein was 5 μg (lane 2) and 25 μg (lane 4); (relative TFIIH levels are as in Figure 4D). TBP did not copurify with this antibody. Lower panel: immunoprecipitation with affinity-purified α-FIR. α-GST was the control (Lane 2). TFIIH copurified with FIR in HeLa and XPD extracts (lanes 3 and 4), but only trace TFIIH purified with FIR from XPB nuclear extract (lane 5) Cell 2001 104, 353-363DOI: (10.1016/S0092-8674(01)00223-9)